GSM Foils reported strong Q1 FY27 performance, with revenue up 86.3% YoY to ₹96.89 Cr and profit after tax (PAT) soaring 98.8% to ₹7.62 Cr.

EPS grew from ₹2.99 to ₹5.41. The company specializes in blister and pharma foils for the growing pharmaceutical sector.

Growth is driven by strategic capacity expansions and product diversification.

GSM Foils recently operationalized a new manufacturing facility in Ahmedabad, expanding capacity and market reach in western and northern India.

A key development is the diversification into Aluminium ROPP Caps from June 2026, with a third manufacturing facility in Mumbai aiming for ₹50 Cr annual revenue potential and higher margins.

Management plans further geographic expansion and technological advancements, including establishing another new manufacturing facility in H1 FY27. The focus remains on becoming a trusted partner for pharma companies, leveraging industry tailwinds from India’s expanding pharmaceutical exports and demand for advanced barrier packaging.